Join to view full profile
UK Medical Oncology800 Rose Street CC401 Roach BuildingLexington, KY 40536
Phone+1 859-323-6522
Fax+1 859-257-3757
Dr. Villano is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2001 - 2004
Cook County Health and Hospitals SystemResidency, Internal Medicine, 1999 - 2001
University of MichiganResidency, Neurology, 1998 - 1999
University of Texas Southwestern Medical SchoolClass of 1997
Certifications & Licensure
KY State Medical License 2011 - 2027
FL State Medical License 2015 - 2017
IL State Medical License 1999 - 2017
MI State Medical License 1998 - 1999
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts FollowMyHealth, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2016-2017
Clinical Trials
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
- Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
Publications & Presentations
PubMed
- 1 citationsPhase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumors.John L Villano, Jason J Luke, Ricklie Julian, Christos Fountzilas, Manish R Patel
Journal for Immunotherapy of Cancer. 2026-02-11 - Safety and efficacy of DLL3 CAR-T cells armored with dnTGFBR2 in a subject with recurrent small-cell lung cancer: case report.Chelsey M Williams, Susanne M Arnold, John L Villano, Erika N Amarilla Alonso, Christine F Brainson
Frontiers in Oncology. 2026-01-01 - Current and emerging therapies targeting cell surface antigens and epigenetics in extensive stage small cell lung cancer: primer for clinicians.Zhonglin Hao, John Villano, Susanne M Arnold, Lowell Anthony
Therapeutic Advances in Medical Oncology. 2026-01-01
Press Mentions
Markey Researchers Identify Genetic Marker That Could Guide Brain Cancer TreatmentJuly 25th, 2025- Ky. Attorney Defies Brain Cancer Odds Through Markey Clinical TrialMay 15th, 2025
- Brain Cancer Awareness: Understanding the Signs, Risks and TreatmentsMay 5th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
